BPMC

Blueprint Medicines Corp (BPMC)

US
$ 96.56996.8%

Price Chart

Key Statistics

Market Cap
$ 8.29B
P/E Ratio
0.00
Revenue (TTM)
$ 562.12M
Volume
1.02M
52W High
$ 128.34
52W Low
$ 73.04
Dividend Yield
0.00%
Beta
0.83

Technicals

50-Day MA
101.3827
200-Day MA
95.4981
52 Week High
128.34
52 Week Low
73.04

About BPMC

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing.

Employees
682
Headquarters
Cambridge, MA
CEO
Ms. Kathryn Haviland M.B.A.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
GNW
Genworth Financial ...
$ 7.80
14.04
GPMT
Granite Point Mortg...
$ 2.55
10.87
JKS
JinkoSolar Holding ...
$ 20.43
6.57
QS
QuantumScape Corpor...
$ 4.47
5.67
RMAX
RE/MAX Holdings Inc...
$ 8.16
5.29

Top Losers

Symbol/Name
LTP
% Chg
ALL
Allstate Corporatio...
$ 191.25
-3.50
UAVS
AgEagle Aerial Syst...
$ 1.25
-3.10
HAL
Halliburton Company...
$ 22.36
-2.82
V
Visa Inc.
$ 349.21
-2.44
UBS
UBS Group AG Regist...
$ 30.83
-2.41